VCAM1 and Familial prostate cancer: Moreover, serum VCAM-1 was the only prognostic factor for patients with stage 3 and stage 4 rectal cancer patients [52] while, in prostate cancer, serum VCAM-1 achieved the status of independent predictor after adjusting for the standard postoperative clinicopathological features [60].